MAP2K4P1: A Protein Involved in Cell Signaling Pathways (G139201)

Target Name: MAP2K4P1

NCBI ID: G139201

MAP2K4P1

Other Name(s): mitogen-activated protein kinase kinase 4 pseudogene 1 | Mitogen-activated protein kinase kinase 4 pseudogene 1

MAP2K4P1: A Protein Involved in Cell Signaling Pathways

MAP2K4P1, also known as mitogen-activated protein kinase kinase 4 pseudogene 1, is a protein that plays a critical role in cell signaling pathways. It is a protein that is expressed in various tissues and cells throughout the body, including the brain, pancreas, and heart.

MAP2K4P1 is a member of the MAP2K4 family of proteins, which are involved in the regulation of cell signaling pathways. These proteins are known for their ability to activated by various signaling molecules, including growth factors and cytokines. Once activated, MAP2K4P1 helps to regulate the following cellular processes:

1. Docking of signaling molecules to their receptors, which is the first step in the signaling pathway.
2. Activation of the protein kinase, which is the second step in the signaling pathway.
3. Phosphorylation of the downstream target protein, which is the final step in the signaling pathway.

MAP2K4P1 is a protein that is expressed in various tissues and cells throughout the body, including the brain, pancreas, and heart. It is highly expressed in the brain, where it is found in the postsynaptic density of neurons. It is also found in the pancreas, where it is involved in the regulation of insulin secretion. Additionally, it is found in the heart, where it is involved in the regulation of contractility.

MAP2K4P1 is a protein that has been shown to be involved in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that MAP2K4P1 is involved in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It is also involved in the regulation of cancer, where it has been shown to be involved in the development and progression of certain types of cancer.

Due to its involvement in various diseases, MAP2K4P1 has been identified as a potential drug target. Researchers are studying the potential benefits and drawbacks of using MAP2K4P1 as a drug target. Some studies have shown that inhibiting MAP2K4P1 may have potential benefits in treating neurodegenerative diseases and certain types of cancer. However, other studies have shown that inhibiting MAP2K4P1 may also have potential drawbacks, such as the potential for adverse side effects.

In conclusion, MAP2K4P1 is a protein that plays a critical role in cell signaling pathways. It is a member of the MAP2K4 family of proteins and is involved in the regulation of various cellular processes. MAP2K4P1 has been shown to be involved in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. As a result, MAP2K4P1 has been identified as a potential drug target, and researchers are studying the potential benefits and drawbacks of using it as a drug.

Protein Name: Mitogen-activated Protein Kinase Kinase 4 Pseudogene 1

The "MAP2K4P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAP2K4P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets